21 stories tagged with #merck, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Merck"
William Blair downgrades Bio-Techne stock rating on Merck acquisition
Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
Merck KGaA (MKGAF) Q1 beat and Bio-Techne deal drive upside, but valuation looks full. Read here for a detailed investment analysis.…
Pfizer vs Merck: Chasing High Yield vs Higher Returns
Jefferies starts Merck KGaA at Hold, sees limited upside
Merck & Co., Inc. (MRK) Shareholder/Analyst Call - Slideshow
2026-05-27. The following slide deck was published by Merck & Co., Inc.…
Merck and Mastercard are seeing real agentic AI results. Both say the plumbing came first.
Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Merck KGaA selects Veeva Vault CRM for global deployment
Merck declares $0.85 quarterly dividend for Q3 2026
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints
Valvoline Coupons & Promo Codes for May 2026
We've gathered all the top Valvoline coupons and promo codes for May 2026, including deals on full synthetic oil changes and other essential maintenance.…
Why is Merck stock surging today?
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a randomized trial…
Merck Secures EU Backing for Keytruda-Padcev in Bladder Cancer Patients Subset - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
Trump Has Been Investing in Companies and Then Pumping Them in His Speeches
This story was originally published by Popular Information, a substack publication to which you can subscribe here. On March 11, President Trump took a tour of a manufacturing faci…
New drug approach offers hope for patients with recurrent aggressive cancers
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.…
Ganna matches Merckx with Giro time trial win
Home favourite Filippo Ganna won the seventh Giro d’Italia time trial of his career on Tuesday to match a record set by one of the sport’s greats Eddy Merckx. The Italian posted 45…